Julia Ritsan
Family Medicine · Middletown, NJNPI 1730178054
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 333 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by AstraZeneca at 44.2% of the total. Among family medicine clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 333 payments — averaging $22.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Novo Nordisk$945
- Boehringer Ingelheim$499
- AbbVie$467
- Amarin Pharma, Inc.$323
- Lilly USA, LLC$290
- plus $2K from 28 others
What the payments were for
- Food & beverage$7,457100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 103 | $3,300 |
| Novo Nordisk | 55 | $945 |
| Boehringer Ingelheim | 17 | $499 |
| AbbVie(2 entities) | 25 | $467 |
| Amarin Pharma, Inc. | 15 | $323 |
| Lilly USA, LLC | 18 | $290 |
| Pfizer | 11 | $151 |
| Kowa Pharmaceuticals America, Inc. | 10 | $130 |
| GSK | 9 | $125 |
| Merck | 8 | $108 |
| Dexcom, Inc. | 2 | $106 |
| Novartis | 5 | $98 |
| Amgen | 6 | $82 |
| Daiichi Sankyo Inc. | 4 | $81 |
| Bayer | 3 | $66 |
| Boston Scientific | 1 | $65 |
| Sanofi-aventis U.S. LLC | 4 | $53 |
| Exact Sciences | 2 | $51 |
| Astellas Pharma US Inc | 3 | $50 |
| Johnson & Johnson | 4 | $48 |
| Phadia US Inc. | 3 | $48 |
| Scilex Pharmaceuticals Inc. | 3 | $43 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $42 |
| Sanofi Pasteur Inc. | 3 | $41 |
| E.r. Squibb & Sons, L.L.C. | 3 | $39 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| IBSA Pharma Inc. | 2 | $31 |
| Esperion Therapeutics, Inc. | 2 | $29 |
| Genentech USA, Inc. | 2 | $28 |
| Irhythm Technologies, Inc. | 1 | $26 |
| Bardy Diagnostics, Inc. | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Clarus Therapeutics Inc. | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,463 in reported general payments places this provider in the 90th percentile of 2,084 family medicine providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alprazolam | 52 | $420 |
| Omeprazole | 14 | $210 |
| Losartan Potassium | 14 | $165 |
| Levothyroxine Sodium | 17 | $114 |
| Atorvastatin Calcium | 15 | $97 |
| Pregabalin | 11 | $86 |
| Zolpidem Tartrate | 15 | $52 |
| Clonazepam | 11 | $50 |
| Diazepam | 12 | $39 |
| Hydrochlorothiazide | 12 | $36 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Middletown
- Mikhail VarshavskiChatham$1.4M
- Janet ColeFar Hills$466K
- Matthew PintoMarlton$239K
- Jennifer CaudleSewell$226K
- Jeffrey LevineNew Brunswick$195K
- Jennifer AmicoNew Brunswick$159K
- Dena LacaraFairfield$122K
- Gaurang BrahmbhattHoboken$89K
- Juan LatorreHoboken$71K
- Sally MravcakJersey City$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.